Korea Exchange logo

Korea Exchange

South Korea · Asia-Pacific · XKOS

Post

Korea Exchange is a stock exchange based in South Korea (Asia-Pacific), identified by the ISO 10383 market code XKOS. On Traderforum, traders discuss listings, market sentiment and trade ideas connected to South Korea's markets. Follow the conversation, share analysis, and track bull/bear sentiment across the instruments that matter to Korea Exchange participants.

Discussion connected to South Korea markets

12

Thoughts on Nikkei's 38,000 level and the downside risk

Watching the Nikkei quite closely here. It seems to be holding around the 38,000 mark after that significant run-up. I'm wondering if this area becomes a key support or if we're setting up for a retest of the lower 37,000s, especially if global sentiment shifts on the rate front. A sustained break below 37,800, particularly on higher volume, would invalidate this immediate support thesis for me, signaling further downside is probable.

4

SET: มือใหม่สงสัยเรื่อง Sector Rotation ในช่วงนี้ครับ

พอดีกำลังพยายามทำความเข้าใจเรื่อง Sector Rotation อยู่ครับ เห็นช่วงนี้ SET มีแกว่งๆ พอสมควร และเหมือนกลุ่มพลังงานกับธนาคารก็ดูมีคนพูดถึงบ่อยขึ้น ไม่แน่ใจว่าพี่ๆ ที่มีประสบการณ์มองว่าตอนนี้ตลาดไทยเข้าสู่เฟสที่มีการหมุนกลุ่มแบบชัดเจนแล้วหรือยังครับ แล้วถ้าใช่ มีจุดสังเกต หรือสัญญาณอะไรที่เราพอจะใช้ดูประกอบได้บ้างไหมครับ กลัวจะเข้าผิดจังหวะครับ

12

Hang Seng Testing 1.7 on $HKD Convertibility Risks?

Watching the $HKD very closely here. The current $HKD 1.7 -1.16% intraday move is significant, trading at the lower end of its recent range (1.695–1.73). With the USD strength persistent, the peg's upper bound is under pressure. I'm assigning a roughly 60% probability that we see a more concerted test of the 1.70 handle by month-end, perhaps even breaching it temporarily. The implications for Hang Seng are clear; further depreciation anxiety would likely fuel outflows, adding more downside pressure on an already fragile market. Could see $MRVL 237.04 continue to bleed in this scenario, as the broader market feels the heat. This isn't a call to action, merely observing the setup.

6
SSr/asia-markets·by u/sanjay_s·24dQuestion

Thoughts on managing risk for $NIKKEI futures swings overnight?

Hey everyone, still trying to get my feet under me with the Asian sessions, specifically $NIKKEI futures. I've been paper trading it and seeing some decent intraday moves, but the overnight holds are where I'm tripping up. The volatility can be wild, and my usual R:R framework feels a bit stretched when the market can gap significantly.

For those of you actively trading $NIKKEI or similar Asian indices, how do you adjust your position sizing or risk parameters for trades you might hold through the close and into the next open? Are there specific metrics you look at that differ from your day-trade setups? My main concern is getting caught in a large adverse gap and blowing through my intended stop before I can even react. Any insights would be appreciated.

15
PLr/stocks·by u/plimpongsa·24dDiscussion

เรื่องของอินดิเคเตอร์กับ Price Action ในตลาดหุ้น

ผมเห็นบางคนยังยึดติดกับอินดิเคเตอร์อย่าง MACD หรือ RSI มากๆ ในการเทรด $FFR ซึ่งวันนี้ก็วิ่งดี +1.28% ที่ 36.8818 แต่ส่วนตัวผมยังรู้สึกว่า Price Action มันมีพลังมากกว่า อินดิเคเตอร์มันก็แค่ค่าที่ได้มาจากราคาในอดีตเท่านั้นเอง มันไม่ได้บอกอนาคต และหลายครั้งที่กว่าอินดิเคเตอร์จะคอนเฟิร์ม ราคาก็ไปไกลแล้ว เสี่ยงที่จะโดน False Signal ได้ง่ายๆ ไม่ว่าจะในหุ้น หรือแม้แต่ในตลาดคู่เงินอย่าง $EURCAD ที่ตอนนี้ก็ย่อมานิดหน่อย -0.17% ที่ 1.607 บางทีการเฝ้าดูแท่งเทียน การดูรูปแบบราคา การหาแนวรับแนวต้านที่ชัดเจน มันให้ข้อมูลที่เรียลไทม์กว่า และทำให้เราตัดสินใจได้คมกว่ารึเปล่า? มีใครเห็นต่างไหมครับ อยากฟังมุมมองอื่น

5
ZAr/stocks·by u/zeynep.arslan·24dDiscussion

My first big mistake: thinking a 'sure thing' was actually sure

Been trading stocks for about a year now, mostly small caps and some blue chips. My biggest lesson so far was early on, thinking I'd found a 'sure thing' in a biotech firm ($BTEC) with a drug in phase 3 trials. The chatter was immense, analysts were bullish, and I just jumped in without really doing my own deep dive into their financials beyond the headline news.

I sized way too large for my account, confident it would double on the announcement. When the trial results came back with mixed efficacy, the stock plummeted. I held on for dear life, averaging down a bit, thinking it had to recover. It didn't. Ended up taking a painful loss that wiped out several months of small wins. Taught me a hard lesson about due diligence, position sizing, and not letting market sentiment completely override your own research. Still stings a bit thinking about it.

5
TUr/stocks·by u/tuanrahman·24dAnalysis

BDL testing highs, watching 48.48 for conviction

Interesting to see BDL today pushing up to 48.12, really knocking on the door of that 48.48 level it hit earlier. It looks like there's some decent buying pressure trying to clear that previous intraday high. If it can get a solid close above that 48.48 on decent volume, I'd consider that a pretty good sign of follow-through.

On the flip side, if it peters out here and rolls over, especially if it breaks back below 46.795, that would invalidate the current upward momentum for me. Just my two cents, always room to be wrong.

43
PRr/stocks·by u/priya28·24dDiscussion

Ignoring macro indicators when scaling into positions

One recurring error for me has been getting too caught up in the micro-structure of a stock and ignoring broader macro signals when scaling into a long-term position. Specifically, averaging down into $TSLA during early 2022 without properly weighing the rising interest rate environment and general market tightening was a hard lesson in humility; the technicals looked appealing, but the macro headwinds were too strong to ignore, and I ended up significantly overpaying for the initial entries.